MAPK/ERK signaling pathway analysis in primary osteoblasts from patients with nonsyndromic sagittal craniosynostosis

Sun Don Kim, Garima Yagnik, Michael L. Cunningham, Jinoh Kim, Simeon A. Boyadjiev

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: The MAPK/ERK signaling pathway has been implicated in several craniosynostosis syndromes and represents a plausible target for therapeutic management of craniosynostosis. The causes of sagittal nonsyndromic craniosynostosis (sNSC) have not been well understood and the role that MAPK/ERK signaling cascade plays in this condition warrants an investigation. We hypothesized that MAPK-signaling is misregulated in calvarial osteoblasts derived from patients with sNSC. Methods: In order to analyze if the MAPK/ERK pathway is perturbed in sNSC, we established primary calvarial osteoblast cell lines from patients undergoing surgery for correction of this congenital anomaly. Appropriate negative and positive control cell lines were used for comparison, and we examined the levels of phosphorylated ERK by immunoblotting. Results: Primary osteoblasts from patients with sNSC showed no difference in ERK1/2 phosphorylation with or without FGF2 stimulation as compared with control osteoblasts. Conclusion: Under the described test conditions, we did not observe convincing evidence that MAPK/ERK signaling contributes to the development of sNSC.

Original languageEnglish (US)
Pages (from-to)115-119
Number of pages5
JournalCleft Palate-Craniofacial Journal
Volume51
Issue number1
DOIs
StatePublished - Jan 2014
Externally publishedYes

Keywords

  • BFGF
  • ERK
  • FGF2
  • FGFRs
  • MAPK
  • Non-syndromic
  • Nonsyndromic
  • Sagittal craniosynostosis

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Oral Surgery

Fingerprint Dive into the research topics of 'MAPK/ERK signaling pathway analysis in primary osteoblasts from patients with nonsyndromic sagittal craniosynostosis'. Together they form a unique fingerprint.

Cite this